COVID-19

Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty

Yuvraj — Wed, 24 Dec 2025 08:26:57 +0000

Pharmaceutical companies are radically redesigning portfolio strategies to survive a "triple threat" environment of scientific complexity, regulatory upheaval like the IRA, and capital scarcity. This analysis explores the shift from efficiency-driven models to resilience-first frameworks, detailing how leaders are embedding optionality into pipelines, embracing modality agnosticism, and using dynamic resource allocation to thrive amidst volatility.

The post Building Resilient Pharma Portfolios in an Era of Scientific and Market Uncertainty first appeared on World Pharma Today.

Nipah Virus Vaccines Enter Clinical Trials in Bangladesh

Yuvraj — Tue, 22 Jul 2025 10:40:27 +0000

Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have demonstrated the ability to treat and prevent infection. While Nipah case numbers remain low, climate change is shifting habitats, bringing fruit bats that transmit and spread the virus in South and […]

The post Nipah Virus Vaccines Enter Clinical Trials in Bangladesh first appeared on World Pharma Today.

Nasal Administration Could Boost HIV And COVID-19 Vaccines

content — Tue, 16 Aug 2022 13:54:40 +0000

A team led by an assistant professor from the University of Minnesota in the US has created a new method to successfully administer vaccines through the mucosal tissues in the nose, which could result in improved defence against pathogens like the COVID-19-causing SARS-CoV-2 virus and the human immunodeficiency virus (HIV). The method was tested on mice […]

The post Nasal Administration Could Boost HIV And COVID-19 Vaccines first appeared on World Pharma Today.